FACTORS ASSOCIATED WITH TOLERANCE TO PHARMACOLOGICAL THERAPY USING TYROSINE KINASE INHIBITORS IN CHRONIC MYELOID LEUKEMIA PATIENTS ATTENDED AT FOSCAL IN THE PERIOD 2013-2020.

Claudia Lucía Sossa; Néstor Gamboa; Luis Antonio Salazar; Ángela María Peña; Gabriela Vesga-Jerez; Ana María Prada-Sepúlveda; María Luna-González; Manuel Rosales; Miguel Ochoa; Virginia Abello

doi:10.1097/01.hs9.0000974756.37063.fe

FACTORS ASSOCIATED WITH TOLERANCE TO PHARMACOLOGICAL THERAPY USING TYROSINE KINASE INHIBITORS IN CHRONIC MYELOID LEUKEMIA PATIENTS ATTENDED AT FOSCAL IN THE PERIOD 2013-2020.

Claudia Lucía Sossa, Néstor Gamboa (Co-autor), Luis Antonio Salazar (Co-autor), Ángela María Peña (Co-autor), Gabriela Vesga-Jerez (Co-autor), Ana María Prada-Sepúlveda (Co-autor), María Luna-González (Co-autor), Manuel Rosales (Co-autor), Miguel Ochoa (Co-autor), Virginia Abello (Co-autor)

Producción científica: Artículos / Notas › Artículo Científico › revisión exhaustiva

Resumen

The aim of this study was to determine the association between clinical characteristics and tolerance to pharmacological therapy with TKIs.

Idioma original	Indefinido/desconocido
Publicación	HemaSphere
DOI	https://doi.org/10.1097/01.hs9.0000974756.37063.fe
Estado	Publicada - 1 ago. 2023

Palabras clave

Tyrosine kinase inhibitor
Chronic myeloid leukemia, Toxicity

Líneas de Investigación UNAB

Medicina Interna

Acceder al documento

10.1097/01.hs9.0000974756.37063.feLicencia: CC BY-NC-ND

Citar esto

Sossa, C. L., Gamboa, N., Salazar, L. A., Peña, Á. M., Vesga-Jerez, G., Prada-Sepúlveda, A. M., Luna-González, M., Rosales, M., Ochoa, M., & Abello, V. (2023). FACTORS ASSOCIATED WITH TOLERANCE TO PHARMACOLOGICAL THERAPY USING TYROSINE KINASE INHIBITORS IN CHRONIC MYELOID LEUKEMIA PATIENTS ATTENDED AT FOSCAL IN THE PERIOD 2013-2020. HemaSphere. https://doi.org/10.1097/01.hs9.0000974756.37063.fe

@article{3285db153f9b4790825fbaeedbe051e0,

title = "FACTORS ASSOCIATED WITH TOLERANCE TO PHARMACOLOGICAL THERAPY USING TYROSINE KINASE INHIBITORS IN CHRONIC MYELOID LEUKEMIA PATIENTS ATTENDED AT FOSCAL IN THE PERIOD 2013-2020.",

abstract = "The aim of this study was to determine the association between clinical characteristics and tolerance to pharmacological therapy with TKIs.",

keywords = "Tyrosine kinase inhibitor, Chronic myeloid leukemia, Toxicity",

author = "Sossa, {Claudia Luc{\'i}a} and N{\'e}stor Gamboa and Salazar, {Luis Antonio} and Pe{\~n}a, {{\'A}ngela Mar{\'i}a} and Gabriela Vesga-Jerez and Prada-Sep{\'u}lveda, {Ana Mar{\'i}a} and Mar{\'i}a Luna-Gonz{\'a}lez and Manuel Rosales and Miguel Ochoa and Virginia Abello",

year = "2023",

month = aug,

day = "1",

doi = "10.1097/01.hs9.0000974756.37063.fe",

language = "Indefinido/desconocido",

journal = "HemaSphere",

issn = "2572-9241",

}

Sossa, CL, Gamboa, N, Salazar, LA, Peña, ÁM, Vesga-Jerez, G, Prada-Sepúlveda, AM, Luna-González, M, Rosales, M, Ochoa, M & Abello, V 2023, 'FACTORS ASSOCIATED WITH TOLERANCE TO PHARMACOLOGICAL THERAPY USING TYROSINE KINASE INHIBITORS IN CHRONIC MYELOID LEUKEMIA PATIENTS ATTENDED AT FOSCAL IN THE PERIOD 2013-2020.', HemaSphere. https://doi.org/10.1097/01.hs9.0000974756.37063.fe

FACTORS ASSOCIATED WITH TOLERANCE TO PHARMACOLOGICAL THERAPY USING TYROSINE KINASE INHIBITORS IN CHRONIC MYELOID LEUKEMIA PATIENTS ATTENDED AT FOSCAL IN THE PERIOD 2013-2020. / Sossa, Claudia Lucía; Gamboa, Néstor (Co-autor); Salazar, Luis Antonio (Co-autor) et al.
En: HemaSphere, 01.08.2023.

Producción científica: Artículos / Notas › Artículo Científico › revisión exhaustiva

TY - JOUR

T1 - FACTORS ASSOCIATED WITH TOLERANCE TO PHARMACOLOGICAL THERAPY USING TYROSINE KINASE INHIBITORS IN CHRONIC MYELOID LEUKEMIA PATIENTS ATTENDED AT FOSCAL IN THE PERIOD 2013-2020.

AU - Sossa, Claudia Lucía

A2 - Gamboa, Néstor

A2 - Salazar, Luis Antonio

A2 - Peña, Ángela María

A2 - Vesga-Jerez, Gabriela

A2 - Prada-Sepúlveda, Ana María

A2 - Luna-González, María

A2 - Rosales, Manuel

A2 - Ochoa, Miguel

A2 - Abello, Virginia

PY - 2023/8/1

Y1 - 2023/8/1

N2 - The aim of this study was to determine the association between clinical characteristics and tolerance to pharmacological therapy with TKIs.

AB - The aim of this study was to determine the association between clinical characteristics and tolerance to pharmacological therapy with TKIs.

KW - Tyrosine kinase inhibitor

KW - Chronic myeloid leukemia, Toxicity

U2 - 10.1097/01.hs9.0000974756.37063.fe

DO - 10.1097/01.hs9.0000974756.37063.fe

M3 - Artículo Científico

SN - 2572-9241

JO - HemaSphere

JF - HemaSphere

ER -